RESULTSParticipantsThere were simil

RESULTS
Participants
There were similar numbers of men and women (table 1) but all practice nurses were female and most primary care physicians were male. Seven participants were from a minority ethnic group (3 Indians; 1 White Irish; 1 Chinese and 2 others). Most gained their professional qualification between 1970 and 1989. Participants had a full range of attitudes towards medicines determined by their BMQ-General score, but the four respondents with more positive attitudes towards medicines were all practice nurses.
Key areas
To facilitate comparison of comments and contextualise subthemes, these are presented within each of the three key areas: attitude towards the polypill; opinions on monitoring and views on prescribing. The number of respondents discussing each subtheme is reported (denominator 16 participants) to contextualise the findings and facilitate a comparison between respondents. Interview extracts representative of each subtheme are shown in boxes 1–3. Comparison of the
subthemes did not reveal any relationship between healthcare professionals’ characteristics and their views on the polypill in managing cardiovascular risk.

Attitude towards the polypill
Healthcare professionals discussed their attitude towards the polypill in terms of what they already knew and understood about it, and their thoughts about using the medication for primary and secondary prevention (box 1).

Would primary healthcare professionals prescribe a polypill?

Box 1 Attitude towards the polypill
Knowledge and understanding of the polypill
Would be used for cardiovascular disease prevention
“[The polypill is]…hoping to reduce heart attacks and heart disease and stroke and things like that really…regardless of whether or not they have hypertension or ischemic heart disease at the time.” (Primary care physician 4)
Uncertainty over aspects of polypill
“…you’re only going to put these people on primary prevention if they’re at risk, aren’t you? It’s not for everybody is it?” (Primary care physician 10)
Knowledge based on journals and media
“…I don’t know what the thinking behind the use of it is other than what I’ve read in the national press.” (Primary care physician 8)
Use of the polypill for primary prevention
Concerns regarding actual polypill
“...one would intellectually feel that if you put five pills in a pill, or four pills in a pill, more people are gonna react to it than if you’ve got one pill.” (Primary care physician 3)
“I think you need titration, individual titration of different medications for individual people...so I can’t imagine that one pill will work for everybody.” (Practice nurse 3)
Unnecessary medicalisation
“...its [the polypill] just another medication that you’d be committing the person to really...I just think it’s unnecessary. I think we should be teaching people, well people, how to keep themselves well without offering them preventive things, in the way of medication that is.” (Practice nurse 1)
Lack of evidence demonstrating effectiveness
“...if you’ve got evidence that it works, then it would be easy for me to support. No, the evidence doesn’t exist.” (Primary care physician 8)
Negative impact on patient lifestyle
“...it may very well give people a false sense of security...they’ll continue to eat and drink too much, and smoke too much and take the polypill...it may make no difference whatsoever to them.” (Primary care physician 4)
May reduce cardiovascular disease risk
“...the possibilities are that it might reduce a population’s risk of heart disease and stroke.” (Primary care physician 11)
“You would reach a population that you wouldn’t otherwise reach, then you’re broadening the service you’re providing and reducing cardiovascular risk.” (Primary care physician 8)
Should only be for those with risk factors
“It [the polypill] should only be for those at risk of a cardiovascular attack...especially if there’s any history of cardiovascular disease in the family.” (Primary care physician 2)
Use of the polypill for secondary prevention
Practical for patients
“...it just saves taking lots of tablets often: I think compliance probably would be better.” (Practice nurse 5)
Lack of purpose
“...secondary prevention: I’m not so sure about because we are supposed to be treating these patients anyway...so there is a question really about...well the purpose really.” (Primary care
physician 11)

Результаты (английский) 1:

RESULTSParticipantsThere were similar numbers of men and women (table 1) but all practice nurses were female and most primary care physicians were male. Seven participants were from a minority ethnic group (Indians 3; 1 White Irish; 1 Chinese and 2 others). Most gained their professional is Crufts qualification between 1970 and 1989. Participants had a full range of attitudes towards medicines determined by their BMQ-General score, but the four respondents with more positive attitudes towards medicines were all practice nurses.Key areasTo facilitate comparison of comments and contextualise subthemes, these are presented within each of the three key areas: attitude towards the polypill; opinions on monitoring and views on prescribing. The number of respondents discussing each subtheme is reported (denominator 16 participants) to contextualise the findings and facilitate a comparison between respondents. Interview extracts representative of each subtheme are shown in boxes 1-3. Comparison of thesubthemes did not reveal any relationship between healthcare professionals ' characteristics and their views on the polypill in managing cardiovascular risk.Attitude towards the polypillHealthcare professionals discussed their attitude towards the polypill in terms of what they already knew and understood about it, and their thoughts about using the medication for primary and secondary prevention (box 1).The would-be primary healthcare professionals prescribe a polypill?Box 1 Attitude towards the polypillKnowledge and understanding of the polypill Would be used for cardiovascular disease prevention "[The polypill is] ... hoping to reduce heart attacks and heart disease and stroke and things like that really ... regardless of whether or not they have hypertension or ischemic heart disease at the time." (Primary care physician 4)Uncertainty over aspects of polypill "... you're only going to put these people on primary prevention if they're at risk, aren't you? It's not for everybody is it? " (Primary care physician 10)Knowledge based on journals and media“… I don't know what the thinking behind the use of it is other than what I've read in the national press. " (Primary care physician 8)Use of the polypill for primary preventionConcerns regarding actual polypill".. .one would intellectually feel that if you put five pills in a pill, or four pills in a pill, more people are going to react to it than if you've got one pill." (Primary care physician 3) "I think you need individual titration, titration of different medications for individual people...so I can't imagine that one pill will work for everybody." (Practice nurse 3)The unnecessary medicalisation"... its [the polypill] just another medication that you'd be committing the person to really ... I just think it's unnecessary. I think we should be teaching people, well people, how to keep themselves well without offering them preventive things, in the way of medication that is. " (Practice nurse 1)Lack of evidence demonstrating effectiveness"... if you've got evidence that it works, then it would be easy for me to support. No, the evidence doesn't exist. " (Primary care physician 8)Negative impact on patient lifestyle".. .it may very well give people a false sense of security ... they'll continue to eat and drink too much and smoke too much and take the polypill...it may make no difference whatsoever to them." (Primary care physician 4)May reduce cardiovascular disease risk"... the possibilities are that it might reduce a population's risk of heart disease and stroke." (Primary care physician 11) "You would reach a population that you wouldn't otherwise reach, then you're broadening the service you're providing and reducing cardiovascular risk." (Primary care physician 8)Should only be for those with risk factors"It [the polypill] should only be for those at risk of a cardiovascular attack.. .especially if there's any history of cardiovascular disease in the family." (Primary care physician 2)Use of the polypill for secondary preventionPractical for patients"... it just saves taking lots of tablets often: I think compliance probably would be better." (Practice nurse 5)Lack of purpose"... secondary prevention: I'm not so sure about because we are supposed to be treating these patients there is a anyway...so question really about ... well the purpose really." (Primary carephysician 11)

Результаты (английский) 2:

RESULTS
Participants
There were similar numbers of men and women (table 1) but all practice nurses were female and most primary care physicians were male. Seven participants were from a minority ethnic group (3 Indians; 1 White Irish; one Chinese and two others). Most gained their professional qualification between 1970 1989. Participants had and a full range of attitudes towards medicines determined by their BMQ-General score, but the four respondents with more positive attitudes towards medicines were all practice nurses.
Key areas
To facilitate comparison of comments and contextualise subthemes, these are presented within each of the three key areas: attitude towards the polypill; opinions on monitoring and views on prescribing. The number of respondents discussing each subtheme is reported (denominator 16 participants) to contextualise the findings and facilitate a comparison between respondents. Interview extracts representative of each subtheme are shown in boxes 1-3. Comparison of the
subthemes did not reveal any relationship between healthcare professionals' characteristics and their views on the polypill in managing cardiovascular risk. Attitude towards the polypill Healthcare professionals discussed their attitude towards the polypill in terms of what they already knew and understood about it, and their thoughts about using the medication for primary and secondary prevention (box 1). Would primary healthcare professionals prescribe a polypill? Box 1 Attitude towards the polypill Knowledge and understanding of the polypill Would be used for cardiovascular disease prevention "[The polypill is] ... hoping to reduce heart attacks and heart disease and stroke and things like that really ... regardless of whether or not they have hypertension or ischemic heart disease at the time. "(Primary care physician 4) Uncertainty over aspects of polypill" ... you're only going to put these people on primary prevention if they're at risk, are not you? It's not for everybody is it? "(Primary care physician 10) Knowledge based on journals and media" ... I do not know what the thinking behind the use of it is other than what I've read in the national press. "( Primary care physician 8) Use of the polypill for primary prevention Concerns regarding actual polypill "... one would feel intellectually that if you put five pills in a pill, or four pills in a pill, more people are gonna react to it than if you've got one pill. "(Primary care physician 3)" I think you need titration, individual titration of different medications for individual people ... so I can not imagine that one pill will work for everybody. "(Practice nurse 3) Unnecessary medicalisation "... its [the polypill] just another medication that you'd be committing the person to really ... I just think it's unnecessary. I think we should be teaching people, well people, how to keep themselves well without offering them preventive things, in the way of medication that is. "(Practice nurse 1) Lack of evidence demonstrating effectiveness" ... if you've got evidence that it works, then it would be easy for me to support. No, the evidence does not exist. "(Primary care physician 8) Negative impact on patient lifestyle" ... it may very well give people a false sense of security ... they'll continue to eat and drink too much, and smoke too much and take the polypill ... it may make no difference whatsoever to them. "(Primary care physician 4) May reduce cardiovascular disease risk" ... the possibilities are that it might reduce a population's risk of heart disease and stroke. "(Primary care physician 11)" You would reach a population that you would not otherwise reach, then you're broadening the service you're providing and reducing cardiovascular risk. "(Primary care physician 8) Should only be for risk factors with those "It [the polypill] should only be for those at risk of a cardiovascular attack ... especially if there's any history of cardiovascular disease in the family." (Primary care physician 2) Use of the polypill for secondary prevention for patients Practical "... it just saves taking lots of tablets often: I think compliance would probably be better." (Practice nurse 5) Lack of purpose "... secondary prevention: I'm not so sure about because we are to be treating supposed these patients anyway ... so there is a question really about ... the purpose really well. "(Primary care physician 11)

Результаты (английский) 3:

RESULTSparticipantsthere were similar numbers of men and women (table 1) but all practice nurses were female and most primary care physicians were male. seven participants were from a minority ethnic group (3 indians; 1 white irish, 1 chinese and two others). most truly their professional qualification between 1970 and 1989. participants had a full range of attitudes towards medicines determined by their BMQ general score, but the four respondents with more positive attitudes towards medicines were all practice nurses.key areasto facilitate comparison of comments and contextualise subthemes, these are presented within each of the three key areas: attitude towards the polypill; opinions on monitoring and views on prescribing. the number of respondents discussing each subtheme is reported (denominator 16 participants) to contextualise the findings and facilitate a comparison between respondents. interview extracts representative of each subtheme are shown in boxes 1–3. comparison of thesubthemes did not reveal any relationship between healthcare professionals' characteristics and their views on the polypill in managing cardiovascular risk.attitude towards the polypillhealthcare professionals on their attitude towards the polypill in terms of what they already knew and understood about it, and their thoughts about using the medication for primary and secondary prevention (box 1).the primary healthcare professionals prescribe a polypill?box 1 attitude towards the polypillknowledge and understanding of the polypillwould be used for cardiovascular disease prevention"[it is] polypill...hoping to reduce heart attacks and heart disease and or and things like that really...regardless of whether or not they have hypertension or ischemic heart disease at the time." (the primary care physician 4)uncertainty over aspects of polypill"...you 're only going to put these people on primary prevention if they're at risk, aren't you? it's not for everybody is it? "(the primary care physician 10)knowledge based on over and media"i don't know what the thinking behind the use of it is other than what i've read in the national press." (the primary care physician 8)use of the polypill for primary preventionconcerns regarding actual polypill"...one would intellectually feel that if you put five pills in a pill, or four pills and a pill, the more people are going to react to it than if you 've got one pill." (the primary care physician 3)"i think you need titration in titration of different medications for individual air. i can't imagine that one pill will work for everybody." (practice nurse 3)Unnecessary medicalisation"...its [the polypill] just another medication that you 'd be committing the person to really... i just think it's unnecessary. i think we should be teaching people, with people, how to keep themselves well without offering them preventive things, in the way of medication that is. "(practice nurse 1)lack of evidence which effectiveness"...if you've got evidence that it works, then it would be easy for me to support. no, the evidence doesn't exist. "(the primary care physician 8)negative impact on patient lifestyle"... it may very well give people a false sense of security...they 'll continue to eat and drink too much, smoke too much and take the polypill... it may make no difference whatsoever to them." (the primary care physician 4)may reduce cardiovascular disease risk"... possibilities are that it might reduce a population's risk of heart disease and or." (the primary care physician 11)"you would reach a population that you wouldn't otherwise reach, then you're broadening the service you're providing and reducing cardiovascular risk." (the primary care physician 8)should only be for those with risk factors"it [the polypill) should only be for those at risk of a cardiovascular attack...especially if there 's any history of cardiovascular disease in the family." (the primary care physician 2)use of the polypill for secondary preventionpractical for patients"... it just saves to the front of the tablets often: i think compliance probably would be better." (practice nurse 5)lack of purpose"...secondary prevention: i 'm not so sure about because we are supposed to be treating these patients anyway air there is a question if the purpose is to...well (primary care."physician 11)